Immune Reconstitution Inflammatory Syndrome Manifesting as Disseminated Tuberculosis, Deep Venous Thrombosis, Encephalopathy and MyelopathyTAHIR, Mohammad; SINHA, Sanjeev; SHARMA, S. K et al.Indian journal of chest diseases & allied sciences. 2008, Vol 50, Num 4, pp 363-364, issn 0377-9343, 2 p.Article

Pilot Assessment of HIV Gene Therapy-Hematopoietic Stem Cell Clinical Trial Acceptability Among Minority Patients and Their AdvisorsKING, William Douglas; WYATT, Gail E; HONGHU LIU et al.Journal of the National Medical Association. 2010, Vol 102, Num 12, pp 1123-1128, issn 0027-9684, 6 p.Article

Safety and Immunogenicity of the Quadrivalent Human Papillomavirus vaccine in HIV-1-Infected MenWILKIN, Timothy; LEE, Jeannette Y; SAAH, Alfred et al.The Journal of infectious diseases. 2010, Vol 202, Num 8, pp 1246-1253, issn 0022-1899, 8 p.Article

A Phase 1 /Pharmacokinetic Study of Sunitinib in Combination With Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus-Positive Patients With Cancer: AIDS Malignancy Consortium Trial AMC 061RUDEK, Michelle A; MOORE, Page C; HAIGENTZ, Missak et al.Cancer. 2014, Vol 120, Num 8, pp 1194-1202, issn 0008-543X, 9 p.Article

Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: Myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patientsAMADO, Rafael G; MITSUYASU, Ronald T; MACPHERSON, Janet L et al.Human gene therapy. 2004, Vol 15, Num 3, pp 251-262, issn 1043-0342, 12 p.Article

A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100-300 CD4⁺ T cellsDE BOER, Alberdina W; MARKOWITZ, Norman; LANE, H. Clifford et al.Clinical immunology (Orlando, Fla. Print). 2003, Vol 106, Num 3, pp 188-196, issn 1521-6616, 9 p.Article